Sabrin Tahri

1.0k total citations
25 papers, 401 citations indexed

About

Sabrin Tahri is a scholar working on Hematology, Oncology and Immunology. According to data from OpenAlex, Sabrin Tahri has authored 25 papers receiving a total of 401 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Hematology, 10 papers in Oncology and 8 papers in Immunology. Recurrent topics in Sabrin Tahri's work include Multiple Myeloma Research and Treatments (15 papers), Chemokine receptors and signaling (8 papers) and Acute Myeloid Leukemia Research (6 papers). Sabrin Tahri is often cited by papers focused on Multiple Myeloma Research and Treatments (15 papers), Chemokine receptors and signaling (8 papers) and Acute Myeloid Leukemia Research (6 papers). Sabrin Tahri collaborates with scholars based in Netherlands, United States and Italy. Sabrin Tahri's co-authors include Irene M. Ghobrial, Oliver Lomas, Tarek H. Mouhieddine, Remco M. Hoogenboezem, Pieter Sonneveld, Mark van Duin, Tom Cupedo, Pieter C. van de Woestijne, Madelon M.E. de Jong and Mathijs A. Sanders and has published in prestigious journals such as Nature Genetics, Blood and Nature Immunology.

In The Last Decade

Sabrin Tahri

23 papers receiving 398 citations

Peers

Countries citing papers authored by Sabrin Tahri

Since Specialization

Citations

This map shows the geographic impact of Sabrin Tahri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sabrin Tahri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sabrin Tahri more than expected).

Fields of papers citing papers by Sabrin Tahri

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sabrin Tahri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sabrin Tahri. The network helps show where Sabrin Tahri may publish in the future.

Co-authorship network of co-authors of Sabrin Tahri

This figure shows the co-authorship network connecting the top 25 collaborators of Sabrin Tahri. A scholar is included among the top collaborators of Sabrin Tahri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sabrin Tahri. Sabrin Tahri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Fixed-duration teclistamab and talquetamab for frail patients with newly diagnosed multiple myeloma: The EMN37 fitfix study 2025 ·Blood ·Sonja Zweegman, Fredrik Schjesvold, Alessandra Larocca, Sabrin Tahri, (unknown), (unknown), (unknown), (unknown), (unknown), Mario Boccadoro, Pieter Sonneveld, Niels W.C.J. van de Donk, María-Victoria Mateos	0
2	An IL-1β-driven neutrophil–stromal cell axis fosters a BAFF-rich protumor microenvironment in individuals with multiple myeloma 2024 ·Nature Immunology ·Madelon M.E. de Jong, (unknown), Natalie Papazian, (unknown), (unknown), (unknown), (unknown), Remco M. Hoogenboezem, (unknown), Sabrin Tahri, Mathijs A. Sanders, Pieter C. van de Woestijne, Francesca Gay, Philippe Moreau, Maike Büttner‐Herold, Heiko Bruns, Mark van Duin, Annemiek Broijl, Pieter Sonneveld, Tom Cupedo	14
3	Interferon gamma‐mediated prevention of tumor progression in a mouse model of multiple myeloma 2024 ·HemaSphere ·Zoltán Kellermayer, Sabrin Tahri, Madelon M.E. de Jong, Natalie Papazian, (unknown), (unknown), Remco M. Hoogenboezem, (unknown), Mathijs A. Sanders, Louis Boon, (unknown), Annemiek Broijl, Pieter Sonneveld, Tom Cupedo	1
4	Clinical Outcomes and Evolution of Clonal Hematopoiesis in Patients with Newly Diagnosed Multiple Myeloma 2023 ·Cancer Research Communications ·Tarek H. Mouhieddine, (unknown), Robert Redd, Andrew Dunford, Matthew Leventhal, Romanos Sklavenitis‐Pistofidis, Sabrin Tahri, Habib El‐Khoury, David P. Steensma, Benjamin L. Ebert, Robert J. Soiffer, Jonathan J. Keats, Shaadi Mehr, Daniel Auclair, Irene M. Ghobrial, Adam S. Sperling, Chip Stewart, Gad Getz	8
5	Single-cell multi-omics of human clonal hematopoiesis reveals that DNMT3A R882 mutations perturb early progenitor states through selective hypomethylation 2022 ·Nature Genetics ·Anna S. Nam, Neville Dusaj, Franco Izzo, (unknown), Robert M. Myers, Tarek H. Mouhieddine, Jesús Alfonso López Sotélo, Salima Benbarche, (unknown), Federico Gaiti, Sabrin Tahri, Ross L. Levine, Omar Abdel‐Wahab, Lucy A. Godley, Ronan Chaligné, Irene M. Ghobrial, Dan A. Landau	59
6	Stromal Cell-Activated Bone Marrow Neutrophils Provide BAFF in Newly Diagnosed and Treated Multiple Myeloma 2022 ·Blood ·Madelon M.E. de Jong, (unknown), Natalie Papazian, (unknown), (unknown), Sabrin Tahri, Remco M. Hoogenboezem, Mark van Duin, Pieter C. van de Woestijne, Anton W. Langerak, Annemiek Broijl, Pieter Sonneveld, Tom Cupedo	2
7	OAB-029: Single-cell transcriptomic analysis reveals reduction of cytotoxic NK cells in a subset of newly diagnosed multiple myeloma patients impacting outcome after daratumumab therapy 2022 ·Clinical Lymphoma Myeloma & Leukemia ·Sabrin Tahri, Madelon M.E. de Jong, (unknown), Natalie Papazian, Zoltán Kellermayer, (unknown), (unknown), Mark van Duin, Pieter C. van de Woestijne, Kazem Nasserinejad, Elona Saraci, Mattia D’Agostino, Francesca Gay, Vincent van der Velden, Sonja Zweegman, Niels W.C.J. van de Donk, Annemiek Broijl, Pieter Sonneveld, Tom Cupedo	1
8	B01: STROMAL CELL-NEUTROPHIL INTERACTIONS PROMOTE A PRO-TUMOR ENVIRONMENT IN MULTIPLE MYELOMA 2022 ·HemaSphere ·Madelon M.E. de Jong, (unknown), (unknown), Natalie Papazian, Sabrin Tahri, Zoltán Kellermayer, (unknown), Mark van Duin, Pieter C. van de Woestijne, Annemiek Broijl, Pieter Sonneveld, Tom Cupedo	0
9	The multiple myeloma microenvironment is defined by an inflammatory stromal cell landscape 2021 ·Nature Immunology ·Madelon M.E. de Jong, Zoltán Kellermayer, Natalie Papazian, Sabrin Tahri, Davine Hofste op Bruinink, Remco M. Hoogenboezem, Mathijs A. Sanders, Pieter C. van de Woestijne, P.K. Bos, Cyrus Khandanpour, Jessica Vermeulen, Philippe Moreau, Mark van Duin, Annemiek Broijl, Pieter Sonneveld, Tom Cupedo	128
10	High Levels of Circulating Tumor Cells Are Associated with Increased Bone Marrow Proliferation in Newly Diagnosed Multiple Myeloma Patients 2021 ·Blood ·(unknown), Madelon M.E. de Jong, Sabrin Tahri, Zoltán Kellermayer, (unknown), (unknown), Natalie Papazian, Mark van Duin, (unknown), Mathijs A. Sanders, Vincent H. J. van der Velden, Pieter Sonneveld, Annemiek Broyl, Tom Cupedo	2
11	OAB-040: Clonal hematopoiesis is associated with increased risk of progression of asymptomatic Waldenström Macroglobulinemia 2021 ·Clinical Lymphoma Myeloma & Leukemia ·Sabrin Tahri, Tarek H. Mouhieddine, Robert Redd, (unknown), (unknown), Nang Kham Su, Habib El‐Khoury, Amin H. Nassar, Elio Adib, (unknown), Sarah Abou Alaiwi, Lorenzo Trippa, David P. Steensma, Jorge J. Castillo, Steven P. Treon, Irene M. Ghobrial, Adam S. Sperling	1
12	Clonal Hematopoiesis Is Associated with Increased Risk of Progression of Asymptomatic Waldenström Macroglobulinemia 2021 ·Blood ·Sabrin Tahri, Tarek H. Mouhieddine, Robert Redd, (unknown), (unknown), Nang Kham Su, Habib El‐Khoury, Amin H. Nassar, Elio Adib, (unknown), Sarah Abou Alaiwi, Lorenzo Trippa, David P. Steensma, Jorge J. Castillo, Steven P. Treon, Irene M. Ghobrial, Adam S. Sperling	1
13	Clonal Hematopoiesis Prevalence Increases throughout Treatment of Newly Diagnosed Multiple Myeloma Patients 2021 ·Blood ·Tarek H. Mouhieddine, (unknown), Robert Redd, Andrew Dunford, Matthew Leventhal, Romanos Sklavenitis‐Pistofidis, Sabrin Tahri, Habib El‐Khoury, David P. Steensma, Benjamin L. Ebert, Robert J. Soiffer, Jonathan J. Keats, Shaadi Mehr, Daniel Auclair, Adam S. Sperling, Chip Stewart, Gad Getz, Irene M. Ghobrial	1
14	Single-Cell Multi-Omics in Human Clonal Hematopoiesis Reveals That DNMT3A R882 Mutations Perturb Early Progenitor States through Selective Hypomethylation 2020 ·Blood ·Anna S. Nam, Neville Dusaj, Franco Izzo, (unknown), Tarek H. Mouhieddine, Robert M. Myers, Jesús Alfonso López Sotélo, Salima Benbarche, Federico Gaiti, Sabrin Tahri, Omar Abdel‐Wahab, Irene M. Ghobrial, Ronan Chaligné, Dan A. Landau	1
15	The microenvironment in myeloma 2019 ·Current Opinion in Oncology ·Oliver Lomas, Sabrin Tahri, Irene M. Ghobrial	46
16	Proteomic characterization of human multiple myeloma bone marrow extracellular matrix 2017 ·Leukemia ·Siobhan Glavey, Alexandra Naba, Salomon Manier, Karl R. Clauser, Sabrin Tahri, Jeong Hyeon Park, Michaela R. Reagan, Michele Moschetta, Yuji Mishima, Manuela Gambella, Alberto Rocci, Antonio Sacco, Michael O’Dwyer, John M. Asara, Antonio Palumbo, Aldo M. Roccaro, Richard O. Hynes, Irene M. Ghobrial	65
17	Intussusception during pregnancy after laparoscopic Roux-en-Y gastric bypass 2014 ·BMJ Case Reports ·Anouk Bokslag, Jiska Jebbink, (unknown), Martijn A. Oudijk, (unknown), Sabrin Tahri, Maria G. van Pampus	12
18	Pulmonary hypertension is a mild comorbidity in end-stage cystic fibrosis patients 2013 ·The Journal of Heart and Lung Transplantation ·(unknown), Maarten J. Cramer, Johanna M. Kwakkel‐van Erp, (unknown), Sabrin Tahri, Harold W. de Valk, Ed A. van de Graaf	18
19	Hépatite aiguë cytolytique induite par l’allopurinol chez un patient traité pour hépatite virale C 2009 ·Journal Africain d Hépato-Gastroentérologie ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Sabrin Tahri, (unknown), (unknown)	1
20	(026) Pseudo-tumoral Crohn’s disease: About 8 cases 2009 ·Arab Journal of Gastroenterology ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Sabrin Tahri, (unknown)	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact